Daxor Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DXR | AVTR | BDX | IMDX | QTRX | ATOS | |
|---|---|---|---|---|---|---|
| Market cap | 60.16M | 10.48B | 51.45B | 103.74M | 149.45M | 23.84M |
| P/E (TTM) | 9.4 | — | 43.9 | — | — | — |
| Forward P/E | — | 17.7 | 14.2 | -4.0 | -2.3 | -0.7 |
| Price/book | 1.2 | 1.9 | 2.1 | -4.9 | 0.6 | 0.9 |
| Dividend yield | — | — | 2.29% | — | — | — |
| 1-year change | −19.18% | +11.36% | +25.22% | −13.59% | −44.22% | −84.51% |
| Today | −1.02% | −1.15% | +2.80% | −5.93% | −3.66% | −2.10% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All DXR news ›Daxor Corporation (NASDAQ:DXR) Sees Large Growth in Short Interest
Posted by Defense World Staff on Oct 12th, 2026 Shares of NASDAQ DXR opened at $10.41 on Monday. The business’s 50 day moving average is $10.60 and its two-hundred day moving average is $10.38. Daxor has a 12 month low of $8.56 and a 12…
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Independent clinical partners will present new data on Saturday,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
defenseworld.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.